Discover iDose TR

If your glaucoma medication is causing issues, take control of your eye pressure with iDose TR, an FDA-approved treatment that helps lower eye pressure with minimal side effects.

In clinical studies, most people who received iDose TR did not experience any serious side effects. The most common side effects of iDose TR (occurring in 6% or fewer people) were increased eye pressure, inflammation of the iris, dry eye, a loss of part of the usual field of vision, eye pain, eye redness, and reduced vision.

What is iDose TR?

iDose TR is the first and only FDA-approved fixed implant that helps lower eye pressure in people with open-angle glaucoma or ocular hypertension.

Barely visible to the human eye, iDose TR is a tiny implant specially designed to continuously release prescription medication directly inside your eye, where it’s needed most.

With iDose TR, you get the prescription medication your eye needs, without the inconvenience of prescription eye drops or the challenges of putting them in the eye.

In clinical studies, the most common side effects of iDose TR (occurring in 6% or fewer people) were increased eye pressure, inflammation of the iris, dry eye, a loss of part of the usual field of vision, eye pain, eye redness, and reduced vision.

Closeup of fingertip pad with the iDose device shown to scale.

Side view of the idose injector application.

Real image of iDose TR

What makes iDose TR unique?

One tiny implant. Convenient long-term eye pressure control.

How your eye can benefit from iDose TR:

24/7 therapy

24/7 therapy

Provides continuous, 24/7 release of medication directly inside the eye to help lower eye pressure.

0 missed doses

Helps you take control of your eye pressure without missing a single dose.

Long-term eye pressure control

Long-term eye pressure control

Shown to reduce eye pressure and help keep it under control for up to 3 years.

FDA-approved iDose TR is proven safe and effective

Designed to help people take long-term control or manage glaucoma
The safety and efficacy of iDose TR were established in 2 large clinical studies of 1150 people with glaucoma or high eye pressure
Proactively lowers eye pressure earlier in the treatment journey, which may help slow the progression of glaucoma and minimize vision loss
Continuously delivers prescription medication without the challenges or inconvenience of a prescription eye drop—in clinical studies, 8 of 10 people were free of prescription eye drops at 12 months with iDose TR

What is the iDose TR procedure like?

iDose TR continuously releases prescription medication directly inside the eye to help reduce high eye pressure.

Here are some facts about the procedure:

Minimally invasive

One iDose TR is carefully placed in each eye through a tiny incision.

Outpatient setting

For most people, the procedure is painless and performed in a facility where you can go home the same day.

Starts working immediately

Medication starts to help lower eye pressure upon administration of iDose TR.

Recovery time and follow-up

People receiving iDose TR typically have a fast recovery time. Most people go home after the procedure and have a quick return to normal activities. Ask your eye doctor about potential side effects, such as eye redness or irritation, and what activities are safe after your procedure. Individual results may vary.

Important Safety Information

iDose TR is gently placed directly inside your eye by your eye doctor.

You should not have iDose TR if you have an infection or suspected infection in your eye or the area surrounding your eye, have corneal endothelial cell dystrophy, a condition in which the clear front layer of your eye (cornea) has lost its ability to work normally as this can cause vision problems, have had a corneal transplant or cells transplanted to the inner layer of the cornea (endothelial cell transplant), are allergic to any of its ingredients, and/or have narrow angles (the iris and the cornea are too close together).

The most common side effect of iDose TR was increased eye pressure. Other common side effects were inflammation of the iris, dry eye, a loss of part of the usual field of vision, eye pain, eye redness and reduced clearness of vision.

Approved Uses

iDose TR (travoprost intracameral implant) is a prescription medicine and drug delivery system for the eye approved to lower eye pressure in patients with open-angle glaucoma or high eye pressure (ocular hypertension).

You are encouraged to report all side effects to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. You may also call Glaukos at 1-888-404-1644.

Important Safety Information

iDose TR is gently placed directly inside your eye by your eye doctor. You should not have iDose TR if you have an infection or suspected infection in your eye or the area surrounding your eye, have corneal endothelial cell dystrophy, a condition in which the clear front layer of your eye (cornea) has lost its ability to work normally as this can cause vision problems, have had a corneal transplant or cells transplanted to the inner layer of the cornea (endothelial cell transplant), are allergic to any of its ingredients, and/or have narrow angles (the iris and the cornea are too close together).